The emerging roles of liver X receptors and their ligands in cancer

Expert Opinion on Therapeutic Targets
Chin-Yo LinKnut R Steffensen

Abstract

Liver X receptors (LXRs) are nuclear receptors with well-known functions in cholesterol transport, fatty acid and glucose metabolism, and modulation of immune responses. Natural and synthetic ligands have been identified and are under development for the treatment of metabolic and inflammatory conditions and diseases. There is mounting evidence pointing to functional roles for LXRs in a variety of malignancies and the potential therapeutic efficacy of their ligands. This review summarizes the discovery and characterization of LXRs and their ligands, surveys their effects and mechanisms of action in cell-based and animal models of cancer, and proposes the future direction of basic and translational studies of LXRs and their ligands in cancer research and therapeutics. Targeting LXRs is a promising strategy for cancer treatment, particularly for those cancers which do not have effective treatment options. Key questions remain, however, regarding the specific mechanisms of action, effects on other target cells within the tumor microenvironment, and receptor status in patient populations. Moreover, LXR ligands optimized for disease-specific functions and cancer-related endpoints are currently not available. These issues represent b...Continue Reading

References

May 1, 1995·Genes & Development·P J WillyD J Mangelsdorf
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·M TeboulJ A Gustafsson
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B A JanowskiD J Mangelsdorf
Apr 29, 1999·Cell·UNKNOWN Nuclear Receptors Nomenclature Committee
Nov 23, 2000·Genes & Development·J R SchultzB Shan
Mar 20, 2002·The Journal of Biological Chemistry·Joyce J RepaDavid J Mangelsdorf
May 3, 2002·Journal of Medicinal Chemistry·Jon L CollinsTimothy M Willson
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sean B JosephPeter Tontonoz
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Bryan A LaffittePeter Tontonoz
Jul 9, 2003·The Journal of Biological Chemistry·Emi KanekoMakoto Makishima
Aug 5, 2004·Journal of Lipid Research·Elaine M QuinetPonnal Nambi
Oct 7, 2004·Molecular Genetics and Metabolism·Keith A HouckThomas P Burris
Nov 24, 2004·The Journal of Biological Chemistry·Radosveta P KoldamovaJohn S Lazo
Dec 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Annabel F ValledorChristopher K Glass
Sep 10, 2005·Journal of Lipid Research·Jogchum PlatRonald P Mensink
Feb 18, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Daniel WalcherNikolaus Marx
Mar 3, 2006·The Journal of Clinical Investigation·Noam Zelcer, Peter Tontonoz
Aug 10, 2006·Molecular and Cellular Endocrinology·Knut R SteffensenClaus Yding Andersen
Sep 7, 2006·Journal of Neuroscience Research·Claudia HindingerStephen A Stohlman
Oct 3, 2006·Nature Genetics·Jason S CarrollMyles Brown
Apr 10, 2007·Biochemical and Biophysical Research Communications·Chih-Pin ChuuShutsung Liao
Jun 5, 2007·PLoS Genetics·Chin-Yo LinEdison T Liu
Jun 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Noam ZelcerPeter Tontonoz
Sep 4, 2007·The Journal of Biological Chemistry·Mark A BirrellMaria G Belvisi
Oct 16, 2007·Molecular Cell·Xiaoling LiLeonard Guarente
Feb 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hyun-Jin KimJan-Ake Gustafsson
Feb 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kathleen SmoakMichael B Fessler
May 10, 2008·Endocrinology·Sang-Nam Lee, Iris Lindberg
Nov 6, 2008·Biochemical Pharmacology·Shigeyuki UnoMakoto Makishima
Jan 27, 2009·Carcinogenesis·Lise-Lotte VedinKnut R Steffensen
Mar 7, 2009·Bioorganic & Medicinal Chemistry Letters·Britt-Marie SwahnJohanna Lindquist

❮ Previous
Next ❯

Citations

Dec 5, 2017·Nature Communications·Gregory SegalaSandrine Silvente-Poirot
Mar 25, 2018·Molecular Carcinogenesis·Qiang WangXiaoli Ju
Sep 1, 2018·Epigenetics : Official Journal of the DNA Methylation Society·Oriana Lo ReManlio Vinciguerra
Jun 5, 2020·Endocrinology·Maud VoisinMichael J Garabedian
Aug 30, 2019·International Journal of Molecular Sciences·Venkat Krishnan SundaramJulien Grenier
Apr 24, 2020·Clinical Chemistry and Laboratory Medicine : CCLM·Aleksei TikhonovAlla Rubina
Aug 19, 2018·Cancer Research·Sandrine Silvente-PoirotMarc Poirot
Dec 23, 2020·International Journal of Molecular Sciences·Shivangi SrivastavaChin-Yo Lin
Mar 6, 2021·Life Sciences·Qiang WangHeng Zhang
Sep 16, 2020·Seminars in Cancer Biology·Diego Gómez-CoronadoMaría E Fernández-Suárez
Apr 6, 2021·Frontiers in Cell and Developmental Biology·Rosa VonaPaola Matarrese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Related Papers

Nature Reviews. Cancer
Chin-Yo Lin, Jan-Åke Gustafsson
Current Opinion in Investigational Drugs
Michael K Hansen, Thomas M Connolly
Archivum Immunologiae Et Therapiae Experimentalis
Mónica Pascual-García, Annabel F Valledor
Current Atherosclerosis Reports
Takashi Nomiyama, Dennis Bruemmer
© 2022 Meta ULC. All rights reserved